Convergence Investment Partners LLC Has $1.38 Million Stake in HCA Healthcare, Inc. $HCA

Convergence Investment Partners LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 385.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,954 shares of the company’s stock after purchasing an additional 2,345 shares during the quarter. Convergence Investment Partners LLC’s holdings in HCA Healthcare were worth $1,379,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. JPL Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $34,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 2.3%

HCA Healthcare stock opened at $422.68 on Friday. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The firm’s fifty day moving average is $478.74 and its 200 day moving average is $485.84. The company has a market capitalization of $93.77 billion, a PE ratio of 14.54, a PEG ratio of 1.34 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the firm earned $6.45 EPS. The firm’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on HCA shares. Wells Fargo & Company lowered their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Mizuho upped their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Sanford C. Bernstein lowered their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. Finally, Stephens reduced their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $517.82.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.